Effects of Bifidobacterium longum 35624 in children and adolescents with irritable bowel syndrome
Biochim Biophys Acta 1608:149154 Tutwiler GF, Kirsch T, Mohrbacher RJ, Ho W (1978) Pharmacologic profile of methyl 2-tetradecylglycidate (McN-3716)an orally effective hypoglycemic agent
Salim HM, Fukuda D, Higashikuni Y et al (2017) Teneligliptin, a dipeptidyl peptidase-4 inhibitor, attenuated pro-inflammatory phenotype of perivascular adipose tissue and inhibited atherogenesis in normoglycemic apolipoprotein-E-deficient mice
As GLP-1 medications improve glucose management and weight decreases, doses of insulin or sulphonylureas often require reduction to prevent hypoglycaemia, but these adjustments should always be clinically supervised
change in physical health